New Launch24 Mar 2025, 06:09 pm
Wanbury Limited to Launch New Iron Tablets and Ketamine Hydrochloride
AI Summary
Wanbury Limited, a pharmaceutical company with a presence in the global API market and domestic branded formulations, has announced the launch of two new products. The first product is an iron supplement under the brand name 'WANRTIRY C-RED' for formulation (Branded generic) div. The second product is KETAMINE HYDROCHLORIDE for API (Bulk Drug) div. The Ketamine is developed by a unique cost competitive process & quality product by In-house R&D team in compliance with all the major pharmacopeia such as USP & EP. Wanbury is commencing supply of Ketamine during this month with export for European markets.
Key Highlights
- Wanbury Limited to launch Branded Hematinic Iron tablets, 'WANRTIRY C-RED'
- Iron supplement helps improving hemoglobin in the blood of individuals especially during pregnancy
- Wanbury to launch API - KETAMINE HYDROCHLORIDE
- Ketamine has annual demand of over 200 tons for both human and veterinary market
- Wanbury commencing supply of Ketamine during this month with export for European markets